Template:Opioid receptor modulators: Difference between revisions
Jump to navigation
Jump to search
imported>Paine Ellsworth (convert to /doc page) |
Matt Pijoan (talk | contribs) m (1 revision imported) |
||
| Line 12: | Line 12: | ||
* [[7-Hydroxymitragynine]] | * [[7-Hydroxymitragynine]] | ||
* [[ψ-Akuammigine]] | * [[ψ-Akuammigine]] | ||
* [[ | * [[α-Chlornaltrexamine]]<!--Irreversible--> | ||
* [[alpha-Narcotine|α-Narcotine]] | * [[alpha-Narcotine|α-Narcotine]] | ||
* [[Acetyldihydrocodeine]] | * [[Acetyldihydrocodeine]] | ||
| Line 24: | Line 24: | ||
* [[Anileridine]] | * [[Anileridine]] | ||
* [[Apparicine]] | * [[Apparicine]] | ||
* [[ | * [[β-Endorphin]] | ||
* [[Bovine adrenal medullary peptide-12P|BAM-12P]] | * [[Bovine adrenal medullary peptide-12P|BAM-12P]] | ||
* [[Bovine adrenal medullary peptide-18P|BAM-18P]] | * [[Bovine adrenal medullary peptide-18P|BAM-18P]] | ||
| Line 37: | Line 37: | ||
* [[Butorphanol]] | * [[Butorphanol]] | ||
* [[Butyrfentanyl]] | * [[Butyrfentanyl]] | ||
* [[ | * [[BW-373U86]] | ||
* [[Carfentanil]] | * [[Carfentanil]] | ||
* [[Casokefamide]] | * [[Casokefamide]] | ||
| Line 134: | Line 134: | ||
* [[Propiram]] | * [[Propiram]] | ||
* [[PZM21]] | * [[PZM21]] | ||
* [[ | * [[Racemethorphan]] | ||
* [[Racemorphan]] | * [[Racemorphan]] | ||
* [[Remifentanil]] | * [[Remifentanil]] | ||
| Line 171: | Line 171: | ||
* [[18-Methoxycoronaridine|18-MC]] | * [[18-Methoxycoronaridine|18-MC]] | ||
* [[alpha-Gliadin|α-Gliadin]] | * [[alpha-Gliadin|α-Gliadin]] | ||
* [[ | * [[β-Chlornaltrexamine]]<!--Irreversible--> | ||
* [[beta-Funaltrexamine|β-Funaltrexamine]]<!--Irreversible--> | * [[beta-Funaltrexamine|β-Funaltrexamine]]<!--Irreversible--> | ||
* [[Akuammine]] | * [[Akuammine]] | ||
* [[Alvimopan]] | * [[Alvimopan]] | ||
* [[ | * [[AM251|AM-251]] | ||
* [[Apigenin]] | * [[Apigenin]] | ||
* [[AT-076]] | * [[AT-076]] | ||
| Line 181: | Line 181: | ||
* [[Bevenopran]] | * [[Bevenopran]] | ||
* [[Catechin]] | * [[Catechin]] | ||
* [[ | * [[Catechin gallate]] | ||
* [[Clocinnamox]]<!--Irreversible--> | * [[Clocinnamox]]<!--Irreversible--> | ||
* [[CTAP]] | * [[CTAP]] | ||
| Line 190: | Line 190: | ||
* [[Diprenorphine]] | * [[Diprenorphine]] | ||
* [[Epicatechin gallate|ECG]] | * [[Epicatechin gallate|ECG]] | ||
* [[ | * [[Epigallocatechin|EGC]] | ||
* [[Epicatechin]] | * [[Epicatechin]] | ||
* [[Eptazocine]] | * [[Eptazocine]] | ||
| Line 245: | Line 245: | ||
* [[AR-M100390|AR-M100390 (ARM390)]] | * [[AR-M100390|AR-M100390 (ARM390)]] | ||
* [[AZD2327]] | * [[AZD2327]] | ||
* [[ | * [[β-Endorphin]] | ||
* [[Bovine adrenal medullary peptide-18P|BAM-18P]] | * [[Bovine adrenal medullary peptide-18P|BAM-18P]] | ||
* [[Biphalin]] | * [[Biphalin]] | ||
| Line 251: | Line 251: | ||
* [[Butorphan]] | * [[Butorphan]] | ||
* [[Butorphanol]] | * [[Butorphanol]] | ||
* [[ | * [[BW-373U86]] | ||
* [[Casokefamide]] | * [[Casokefamide]] | ||
* [[Cebranopadol]] | * [[Cebranopadol]] | ||
| Line 303: | Line 303: | ||
* [[Pethidine|Pethidine (meperidine)]] | * [[Pethidine|Pethidine (meperidine)]] | ||
* [[Proglumide]] | * [[Proglumide]] | ||
* [[ | * [[Racemethorphan]] | ||
* [[Racemorphan]] | * [[Racemorphan]] | ||
* [[RWJ-394674]] | * [[RWJ-394674]] | ||
| Line 313: | Line 313: | ||
* [[TH-030418]] | * [[TH-030418]] | ||
* [[Thebaine]] | * [[Thebaine]] | ||
* [[ | * [[Thiobromadol|Thiobromadol (C-8813)]] | ||
* [[Tonazocine]] | * [[Tonazocine]] | ||
* [[Tramadol]] | * [[Tramadol]] | ||
| Line 325: | Line 325: | ||
* [[6β-Naltrexol-d4]] | * [[6β-Naltrexol-d4]] | ||
* [[alpha-Santolol|α-Santolol]] | * [[alpha-Santolol|α-Santolol]] | ||
* [[ | * [[β-Chlornaltrexamine]]<!--Irreversible--> | ||
* [[Apigenin]] | * [[Apigenin]] | ||
* [[AT-076]] | * [[AT-076]] | ||
| Line 332: | Line 332: | ||
* [[7-Benzylidenenaltrexone|BNTX]]<!--Selective δ1 antagonist--> | * [[7-Benzylidenenaltrexone|BNTX]]<!--Selective δ1 antagonist--> | ||
* [[Catechin]] | * [[Catechin]] | ||
* [[ | * [[Catechin gallate]] | ||
* [[Clocinnamox]] | * [[Clocinnamox]] | ||
* [[Diacetylnalorphine]] | * [[Diacetylnalorphine]] | ||
* [[Diprenorphine]] | * [[Diprenorphine]] | ||
* [[Epicatechin gallate|ECG]] | * [[Epicatechin gallate|ECG]] | ||
* [[ | * [[Epigallocatechin|EGC]] | ||
* [[Eluxadoline]] | * [[Eluxadoline]] | ||
* [[Epicatechin]] | * [[Epicatechin]] | ||
| Line 376: | Line 376: | ||
* [[18-Methoxycoronaridine|18-MC]] | * [[18-Methoxycoronaridine|18-MC]] | ||
* [[14-Methoxymetopon]] | * [[14-Methoxymetopon]] | ||
* [[ | * [[β-Chlornaltrexamine]] | ||
* [[beta-Funaltrexamine|β-Funaltrexamine]] | * [[beta-Funaltrexamine|β-Funaltrexamine]] | ||
* [[Adrenorphin|Adrenorphin (metorphamide)]] | * [[Adrenorphin|Adrenorphin (metorphamide)]] | ||
| Line 392: | Line 392: | ||
* [[Butorphan]] | * [[Butorphan]] | ||
* [[Butorphanol]] | * [[Butorphanol]] | ||
* [[ | * [[BW-373U86]] | ||
* [[Cebranopadol]] | * [[Cebranopadol]] | ||
* [[Ciprefadol]] | * [[Ciprefadol]] | ||
| Line 469: | Line 469: | ||
* [[Phenazocine]] | * [[Phenazocine]] | ||
* [[Proxorphan]] | * [[Proxorphan]] | ||
* [[ | * [[Racemethorphan]] | ||
* [[Racemorphan]] | * [[Racemorphan]] | ||
* [[RB-64]]<!--Biased agonist--> | * [[RB-64]]<!--Biased agonist--> | ||
| Line 481: | Line 481: | ||
* [[Tifluadom]] | * [[Tifluadom]] | ||
* [[Tricyclic antidepressant]]s (e.g., [[amitriptyline]], [[desipramine]], [[imipramine]], [[nortriptyline]]) | * [[Tricyclic antidepressant]]s (e.g., [[amitriptyline]], [[desipramine]], [[imipramine]], [[nortriptyline]]) | ||
* [[U- | * [[U-50,488]] | ||
* [[U-54,494A]] | * [[U-54,494A]] | ||
* [[U-69,593]] | * [[U-69,593]] | ||
| Line 492: | Line 492: | ||
* [[6β-Naltrexol]] | * [[6β-Naltrexol]] | ||
* [[6β-Naltrexol-d4]] | * [[6β-Naltrexol-d4]] | ||
* [[ | * [[β-Chlornaltrexamine]]<!--Irreversible--> | ||
* [[Buprenorphine/samidorphan]] | * [[Buprenorphine/samidorphan]] | ||
* [[Amentoflavone]] | * [[Amentoflavone]] | ||
| Line 505: | Line 505: | ||
* [[Buprenorphine]] | * [[Buprenorphine]] | ||
* [[Catechin]] | * [[Catechin]] | ||
* [[ | * [[Catechin gallate]] | ||
* [[CERC-501|CERC-501 (LY-2456302)]] | * [[CERC-501|CERC-501 (LY-2456302)]] | ||
* [[Clocinnamox]] | * [[Clocinnamox]] | ||
| Line 511: | Line 511: | ||
* [[Dezocine]] | * [[Dezocine]] | ||
* [[DIPPA]]<!--Irreversible--> | * [[DIPPA]]<!--Irreversible--> | ||
* [[ | * [[Epigallocatechin|EGC]] | ||
* [[Epicatechin gallate|ECG]] | * [[Epicatechin gallate|ECG]] | ||
* [[Epicatechin]] | * [[Epicatechin]] | ||
| Line 573: | Line 573: | ||
* [[Nociceptin (1-13)NH2|Nociceptin (1-13)NH<sub>2</sub>]] | * [[Nociceptin (1-13)NH2|Nociceptin (1-13)NH<sub>2</sub>]] | ||
* [[Norbuprenorphine]] | * [[Norbuprenorphine]] | ||
* [[ | * [[Racemethorphan]] | ||
* [[Racemorphan]] | * [[Racemorphan]] | ||
* [[Ro64-6198]] | * [[Ro64-6198]] | ||
| Line 653: | Line 653: | ||
}}<noinclude> | }}<noinclude> | ||
{{ | {{collapsible option}} | ||
[[Category:Drug templates by receptor, channel, or pump]] | |||
</noinclude> | </noinclude> | ||
Latest revision as of 07:24, 10 January 2019
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Opioid receptor modulators|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Opioid receptor modulators|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Opioid receptor modulators|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.